APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 23 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $623,398 | +207.8% | 504,000 | +362.4% | 0.00% | – |
| Q1 2023 | $202,536 | +4300.1% | 109,000 | +3533.3% | 0.00% | – |
| Q4 2022 | $4,603 | -98.4% | 3,000 | -98.0% | 0.00% | – |
| Q3 2022 | $292,000 | -50.3% | 150,000 | -61.8% | 0.00% | – |
| Q2 2022 | $587,000 | +894.9% | 393,000 | +962.2% | 0.00% | – |
| Q1 2022 | $59,000 | -97.7% | 37,000 | -98.3% | 0.00% | -100.0% |
| Q3 2021 | $2,607,000 | -88.2% | 2,126,000 | -82.3% | 0.00% | -84.6% |
| Q2 2021 | $22,158,000 | +100618.2% | 12,018,000 | +75012.5% | 0.01% | – |
| Q1 2021 | $22,000 | -12.0% | 16,000 | +6.7% | 0.00% | – |
| Q4 2020 | $25,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |